Skip to Content

SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))

Pill with imprint SZ 469 is White, Elliptical / Oval and has been identified as Glimepiride and pioglitazone hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc..

Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 469

Glimepiride and pioglitazone hydrochloride

SZ 469
4 mg / 30 mg (base)
Elliptical / Oval
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.